These compounds may interact with:
G-protein coupled bile acid receptor 1
Potentially involved in: cholestasis; obesity; diabetes mellitus; cholangitis; fatty liver disease; leber congenital amaurosis; polycystic liver disease; liver disease; constipation; crohn disease; fibroadenoma; tuberculosis; primary cholangitis
Disease data sourced from Pharos.